Saturday, August 9th, 2014

DUBLIN, IRELAND -- (Marketwired) -- Research and Markets (http://www.researchandmarkets.com/research/hqvwb6/insulin_pumps) has announced the addition of the "Insulin Pumps (External) - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

Key Topics Covered:

I.  INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 
    
II. EXECUTIVE SUMMARY 

1.  INDUSTRY OVERVIEW 
    
2.  COMPETITIVE ANALYSIS 
    

--  Insulin Pumps Market 
--  Set for Interesting Road Ahead 
--  Comparison of Select Insulin Pumps by Manufacturer 
--  Competition Heats Up in the Patch Pumps Market 
--  Tough Ground for New Entrants

3.  MARKET TRENDS AND ISSUES

--  The Rise of Smart Pumps 
--  A Major Game Changer 
--  Artificial Pancreas System (APS) 
--  The Future of Diabetes Care 
--  Type II Diabetes 
--  A Market with Significant Potential 
--  The Risk of Diabetes in Aging Populace Presents Opportunities for
    Insulin Pumps 
--  Alarming Rise in Obesity 
--  A Business Case for Diabetes Care 
--  Diabetes in Developing Countries to Expand Opportunities

4.  CHALLENGES

--  Implantable Insulin Pumps 
--  A Potential Threat to External Insulin Pumps 
--  Insulin Pump Training 
--  Not Receiving Adequate Attention 
--  Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged 
--  Competition from Other Insulin Delivery Technologies Continues 
--  Undiagnosed Diabetes 
--  A Key Challenge 
--  Lantus: A Threat to Insulin Pump Manufacturers

5.  DIABETES - INCIDENCE AND PREVALENCE

--  Diabetes 
--  Assessing the Economic Burden 
--  A Demographic Analysis by Geographic Region 
--  North America 
--  United States 
--  Canada 
--  Mexico 
--  Europe 
--  Asia-Pacific 
--  Southeast Asian Region 
--  Western Pacific Region 
--  South & Central America 
--  Type-1 Diabetes 
--  Type-2 Diabetes

6.  DIABETES & INSULIN AN ABSTRACT

--  Diabetes 
--  A Fatal Disease 
--  Risk Factors for Diabetes 
--  Types of Diabetes 
--  Long Term Complications of Diabetes 
--  Testing Sugar Levels: Easy and Accurate 
--  Insulin 
--  Pancreas: The Main Source of Insulin in Human Body 
--  Types of Insulin 
--  Types of Insulin & Onset of Action 
--  Goal of Insulin Therapy 
--  Insulin Delivery Systems

7.  PRODUCT OVERVIEW

--  Evolution of Insulin Pumps 
--  Insulin Pump 
--  A Replica of Pancreas 
--  Advantages 
--  More Accurate and Consistent 
--  Enhances Blood Sugar Control in Pediatric Patients 
--  Adjusting Time Zones While Traveling 
--  Improves Quality of Life 
--  Patient Convenience 
--  Components of Insulin Pump 
--  How Does an Insulin Pump Work? 
--  Value-added Features of Modern Insulin Pumps 
--  Bolus Calculators 
--  Insulin On Board 
--  Customized Alarms 
--  Touch Bolus 
--  Interface to PCs

8.  PRODUCT INNOVATIONS/INTRODUCTIONS

--  Debiotech to Unveil Jewel Pump 2 
--  Cellnovo Introduces Novel Insulin Pump System 
--  J&J Introduces Animas Vibe in Canada 
--  Tandem Introduces New Insulin Pump, t:slim, with a Touch Screen

9.  RECENT INDUSTRY ACTIVITY

--  Roche and Novo Nordisk Team Up for Insulin Pump Cartridge 
--  Medtronic Secures FDA Approval for MiniMed 530G 
--  LifeScan Acquires Calibra Medical 
--  Mediq Takes Over Diabetes Specialty Center 
--  Indutrade to Acquire Rubin Medical 
--  Cellnovo Obtains CE Mark for Patch Pump 
--  Asante Secures 510 (K) Approval 
--  Medtronic and Bayer HealthCare Expand Collaboration to Cover US Market 
--  Insulet Acquires Neighborhood Diabetes

10. FOCUS ON SELECT KEY PLAYERS

--  Animas Corp. (USA) 
--  Debiotech S.A. (Switzerland) 
--  F. Hoffmann-La Roche, Ltd. (Switzerland) 
--  Insulet Corp. (USA) 
--  Medtronic (USA) 
--  Medtronic Diabetes (USA) 
--  Sooil Development Co. Ltd. (Korea) 
--  Tandem Diabetes Care Inc. (USA) 
--  Valeritas Inc. (US) 
--  Ypsomed Holding AG (Switzerland)

11. GLOBAL MARKET PERSPECTIVE

III.MARKET 

1.  THE UNITED STATES 
    
2.  CANADA 
    
3.  JAPAN 
    
4.  EUROPE 
    
5.  ASIA-PACIFIC 
    
6.  LATIN AMERICA 
    
7.  REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 13 (including Divisions/Subsidiaries 16)

--  The United States (10) 
--  Europe (4) 
--  Asia-Pacific (Excluding Japan) (2) 

For more information visit http://www.researchandmarkets.com/research/hqvwb6/insulin_pumps

Sector: Drug Delivery

Contacts:
Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Keywords

Research and Markets, market research, external insulin pumps, marketing, report, diabetes, drug delivery, health

Categories

Sharing

More Formats